The most statistically significant anti-proliferative effect of MGN was observed in TE671 rhabdomyosarcoma cell line, whereas MDA-MB-468 cells were the most resistant for MGN treatment among all analyzed cancer cell lines (Figure 4). The gene discussed is HELT; the disease is rhabdomyosarcoma.